Comparison of intermediate-term outcomes of coronary artery bypass grafting versus drug-eluting stents for patients ≥75 years of age

Am J Cardiol. 2014 Mar 1;113(5):803-8. doi: 10.1016/j.amjcard.2013.11.035. Epub 2013 Dec 12.

Abstract

Several randomized controlled trials and observational studies have compared outcomes of percutaneous coronary interventions (PCIs) with drug-eluting stents (DESs) and coronary artery bypass grafting (CABG), but they have not thoroughly investigated the relative difference in outcomes for patients aged ≥75 years. In this study, a total of 3,864 patients receiving DES and CABG (1,932 CABG-DES pairs) with multivessel coronary disease were propensity matched using multiple patient risk factors and were compared with respect to 3 outcomes (mortality, stroke/myocardial infarction [MI]/mortality, and repeat revascularization) at 2.5 years with a mean follow-up of 18 months. The mortality rates (DES/CABG hazard ratio 1.06, 95% confidence interval 0.87 to 1.30) and the stroke/MI/mortality rates (DES/CABG hazard ratio 1.15, 95% confidence interval 0.97 to 1.38) for the 2 procedures were not significantly different. Repeat revascularization rates were significantly higher for patients who received DESs. In conclusion, older patients experienced similar mortality and stroke/MI/mortality rates for CABG and PCI with DES, although repeat revascularization rates were higher for patients undergoing PCI with DES.

Publication types

  • Comparative Study
  • Observational Study
  • Research Support, N.I.H., Extramural

MeSH terms

  • Aged
  • Aged, 80 and over
  • Comorbidity
  • Comparative Effectiveness Research
  • Coronary Artery Bypass*
  • Coronary Artery Disease / blood
  • Coronary Artery Disease / epidemiology
  • Coronary Artery Disease / mortality
  • Coronary Artery Disease / surgery
  • Coronary Artery Disease / therapy*
  • Coronary Stenosis / epidemiology
  • Creatinine / blood
  • Diabetic Angiopathies / surgery
  • Diabetic Angiopathies / therapy
  • Drug-Eluting Stents*
  • Female
  • Humans
  • Kaplan-Meier Estimate
  • Male
  • Percutaneous Coronary Intervention*
  • Propensity Score
  • Pulmonary Disease, Chronic Obstructive / epidemiology
  • Registries
  • Retreatment
  • Risk Factors
  • Treatment Outcome

Substances

  • Creatinine